American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6399)
  2. Solid Tumor Oncology Division (5537)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1379)
  9. Gastrointestinal Oncology Service (1353)
  10. Hematologic Malignancies, Division of (1281)
Search Within
Formats
  1. Meeting Abstract (6334)
  2. Journal Article (2579)
  3. Editorial (76)
  4. Review (68)
  5. Guidelines (54)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6399)
  2. Solid Tumor Oncology Division (5537)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (275)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8694)
  2. JCO Precision Oncology (171)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (7)

More Publications

Results (9167)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Global retrospective study comparing consolidation ALK tyrosine kinase inhibitors (TKI) to durvalumab (durva) or observation (obs) after chemoradiation (CRT) in unresectable locally-advanced ALK plus non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Jayakrishnan, R.; Nassar, A.; Shepherd, F. A.; Lin, J. J.; Lin, S. H.; Shakya, P.; Dilling, T. J.; Bar, J.; Grohe, C.; Gupta, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Hope drives quality of life in patients with brain metastases, but the hope center remains elusive: An analysis of NRG-CC003
    Meeting Abstract

    Corn, B. W.; Paulus, R.; Gondi, V.; Mehta, M. P.; Fogh, S. E.; Wefel, J. S.; Videtic, G. M. M.; Sun, A.; Yoon, H.; Heinzerling, J. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair-deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study
    Meeting Abstract

    Rojas, C.; Eskens, F.; Ghiringhelli, F.; Özgüroglu, M.; Caglevic, C.; Gumus, M.; Tosi, D.; Grenier, J.; Gonzalez, A. F.; Arenas, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026)
    Meeting Abstract

    Erickson, B. K.; Enserro, D.; Lankes, H. A.; Dockery, L. E.; Ghamande, S. A.; Oliver, M. T.; Gressel, G. M.; Castellano, T.; Ratner, E.; Deery, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Avelumab plus axitinib vs sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC): Final overall survival (OS) analysis from the JAVELIN Renal 101 phase 3 trial
    Meeting Abstract

    Motzer, R. J.; Penkov, K.; Uemura, H.; Campbell, M. T.; Kollmannsberger, C. K.; Lee, J. L.; Venugopal, B.; Van Den Eertwegh, A.; Negrier, S.; Gurney, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy and in combination with pembrolizumab, in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer (R/M HNSCC)
    Meeting Abstract

    Colevas, A. D.; Chung, C. H.; Adkins, D.; Rodriguez, C. P.; Park, J. C.; Gibson, M. K.; Sukari, A.; Worden, F. P.; Johnson, F. M.; Saba, N. F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Peak study: A phase 3, randomized, open-label multi-center clinical study of bezuclastinib (CGT9486) and sunitinib combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Tap, W. D.; Somaiah, N.; Kang, Y. K.; Ryan, A.; Razak, A.; Garrido, M.; Desar, I. M. E.; Italiano, A.; Reichardt, P.; Wilky, B. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlative biomarker analyses for optimal therapeutic dose determination of ABBV-383, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ahsan, A.; Mantis, C.; Luo, X.; Zhang, C. C.; Valdes, C. R.; Voorhees, P. M.; D'Souza, A.; Chung, A.; Tuchman, S.; Safah, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of cytokine release syndrome (CRS) in patients with relapsed or refractory multiple myeloma (RRMM) receiving step-up priming doses and longer dosing intervals of elranatamab: MagnetisMM-9
    Meeting Abstract

    Sborov, D. W.; Pawlyn, C.; Ishida, T.; Huang, J. S. Y.; Benjamin, R.; Iida, S.; Popat, R.; Kuroda, J.; Pianko, M. J.; Ramakrishnan, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • NRG Oncology/RTOG 0848: Results after adjuvant chemotherapy +/- chemoradiation for patients with resected periampullary pancreatic adenocarcinoma (PA)
    Meeting Abstract

    Abrams, R. A.; Winter, K. A.; Goodman, K. A.; Regine, W.; Safran, H.; Berger, A. C.; Guha, C.; Kachnic, L. A.; Gillin, M.; Seaward, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save